바이오테크놀러지 시장 규모, 점유율, 동향, 산업 분석 보고서 : 기술별, 용도별, 지역별 - 시장 예측(2025-2034년)

The biotechnology market size is expected to reach USD 5.85 trillion by 2034, according to a new study by Polaris Market Research. The report "Biotechnology Market Size, Share, Trends, Industry Analysis Report: By Technology, Application (Bioinformatics, Food & Agriculture, Health, Industrial Processing, Natural Resources and Environment, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increase in the incidence of chronic diseases and the introduction of innovative treatments are driving the growth of biotechnology market revenue. Biotechnology proves highly beneficial in the treatment of many diseases, with the pharmaceutical industry employing biotechnological techniques from cultivating antibiotic-producing microorganisms in fermentation broth to obtaining a purified antibiotic product. Furthermore, the application of modern biotechnology has the potential to enhance the effectiveness of numerous disease-specific advanced therapeutic approaches. Biotechnology plays a crucial role in the healthcare system, contributing significantly to the production of numerous drugs and vaccines used in the treatment of various diseases. Additionally, various other medical procedures integral to the healthcare system involve the utilization of biotechnology.

The increasing desire for organic food products underscores the indispensability of biotechnology in the agricultural sector, contributing to the market's revenue growth. Biotechnology provides farmers with technologies that can render output more cost-effective and manageable. For instance, certain biotech crops can be genetically modified to withstand specific herbicides, enhancing the efficiency and effectiveness of weed control. Additionally, biotechnology supports breeding crops to be resistant to particular plant diseases and insect pests, due to which it becomes possible to minimize the use of synthetic pesticides and enhance pest control. These options in crop production not only reduce production costs but also aid countries in meeting the demand for food.

Biotechnology Market Report Highlights

The DNA sequencing segment accounted for largest share in 2024 due to increase in government fundings in the genetic research

The health segment is market is expected to experience significant growth in the biotechnology market due to the increasing burden of diseases worldwide.

The Asia Pacific region is experiencing significant growth in the global market due to increasing investments, enhancements in healthcare infrastructure, favorable government initiatives, and strategic expansion efforts by key market players

In 2024, North America biotechnology market recorded largest revenue due to presence of key players, extensive research and development activities, and substantial healthcare expenditure.

The global key market players are Abbott Laboratories; Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; Johnson & Johnson Services, Inc.; Lonza; Merck KGaA; Novartis AG; Novo Nordisk A/S; Pfizer, Inc and Sanofi.

Polaris market research has segmented the biotechnology market report based on technology, application and region:

By Technology (Revenue - USD Trillion, 2020-2034)

§ Fermentation

§ Tissue Engineering and Regeneration

§ Chromatography

§ PCR Technology

§ Nanobiotechnology

§ Cell-based Assays

§ DNA Sequencing

§ Others

By Application (Revenue - USD Trillion, 2020-2034)

§ Bioinformatics

§ Food & Agriculture

§ Health

§ Industrial Processing

§ Natural Resources & Environment

§ Others

By Regional Outlook (Revenue - USD Trillion, 2020-2034)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of APAC
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Biotechnology Market Insights

• 4.1. Biotechnology Market - Market Snapshot
• 4.2. Biotechnology Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Prevalence of Chronic Illnesses
    • 4.2.1.2. Rising Demand in Agriculture
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of Skilled Workforce
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Biotechnology Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Biotechnology Market, by Technology

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
• 5.3. Fermentation
  • 5.3.1. Global Biotechnology Market, by Fermentation, by Region, 2020-2034 (USD Trillion)
• 5.4. Tissue Engineering and Regeneration
  • 5.4.1. Global Biotechnology Market, by Tissue Engineering and Regeneration, by Region, 2020-2034 (USD Trillion)
• 5.5. Chromatography
  • 5.5.1. Global Biotechnology Market, by Chromatography, by Region, 2020-2034 (USD Trillion)
• 5.6. PCR Technology
  • 5.6.1. Global Biotechnology Market, by PCR Technology, by Region, 2020-2034 (USD Trillion)
• 5.7. Nanobiotechnology
  • 5.7.1. Global Biotechnology Market, by Nanobiotechnology, by Region, 2020-2034 (USD Trillion)
• 5.8. DNA Sequencing
  • 5.8.1. Global Biotechnology Market, by DNA Sequencing, by Region, 2020-2034 (USD Trillion)
• 5.9. Others
  • 5.9.1. Global Biotechnology Market, by Others, by Region, 2020-2034 (USD Trillion)

6. Global Biotechnology Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Biotechnology Market, by Application, 2020-2034 (USD Trillion)
• 6.3. Bioinformatics
  • 6.3.1. Global Biotechnology Market, by Bioinformatics, by Region, 2020-2034 (USD Trillion)
• 6.4. Food & Agriculture
  • 6.4.1. Global Biotechnology Market, by Food & Agriculture, by Region, 2020-2034 (USD Trillion)
• 6.5. Health
  • 6.5.1. Global Biotechnology Market, by Health, by Region, 2020-2034 (USD Trillion)
• 6.6. Industrial Processing
  • 6.6.1. Global Biotechnology Market, by Industrial Processing, by Region, 2020-2034 (USD Trillion)
• 6.7. Natural Resources & Environment
  • 6.7.1. Global Biotechnology Market, by Natural Resources & Environment, by Region, 2020-2034 (USD Trillion)
• 6.8. Others
  • 6.8.1. Global Biotechnology Market, by Others, by Region, 2020-2034 (USD Trillion)

7. Global Biotechnology Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Biotechnology Market Assessment, By Geography, 2020-2034 (USD Trillion)
• 7.3. Biotechnology Market - North America
  • 7.3.1. North America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 7.3.2. North America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.3.3. Biotechnology Market - U.S.
    • 7.3.3.1. U.S.: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.3.3.2. U.S.: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.3.4. Biotechnology Market - Canada
    • 7.3.4.1. Canada: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.3.4.2. Canada: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
• 7.4. Biotechnology Market - Europe
  • 7.4.1. Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 7.4.2. Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.3. Biotechnology Market - UK
    • 7.4.3.1. UK: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.3.2. UK: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.4. Biotechnology Market - France
    • 7.4.4.1. France: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.4.2. France: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.5. Biotechnology Market - Germany
    • 7.4.5.1. Germany: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.5.2. Germany: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.6. Biotechnology Market - Italy
    • 7.4.6.1. Italy: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.6.2. Italy: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.7. Biotechnology Market - Spain
    • 7.4.7.1. Spain: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.7.2. Spain: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.8. Biotechnology Market - Netherlands
    • 7.4.8.1. Netherlands: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.8.2. Netherlands: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.9. Biotechnology Market - Russia
    • 7.4.9.1. Russia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.9.2. Russia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.4.10. Biotechnology Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.4.10.2. Rest of Europe: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
• 7.5. Biotechnology Market - Asia Pacific
  • 7.5.1. Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 7.5.2. Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.3. Biotechnology Market - China
    • 7.5.3.1. China: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.3.2. China: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.4. Biotechnology Market - India
    • 7.5.4.1. India: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.4.2. India: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.5. Biotechnology Market - Malaysia
    • 7.5.5.1. Malaysia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.5.2. Malaysia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.6. Biotechnology Market - Japan
    • 7.5.6.1. Japan: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.6.2. Japan: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.7. Biotechnology Market - Indonesia
    • 7.5.7.1. Indonesia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.7.2. Indonesia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.8. Biotechnology Market - South Korea
    • 7.5.8.1. South Korea: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.8.2. South Korea: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.9. Biotechnology Market - Australia
    • 7.5.9.1. Australia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.9.2. Australia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.5.10. Biotechnology Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.5.10.2. Rest of Asia Pacific: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
• 7.6. Biotechnology Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 7.6.2. Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6.3. Biotechnology Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.3.2. Saudi Arabia: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6.4. Biotechnology Market - UAE
    • 7.6.4.1. UAE: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.4.2. UAE: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6.5. Biotechnology Market - Israel
    • 7.6.5.1. Israel: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.5.2. Israel: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6.6. Biotechnology Market - South Africa
    • 7.6.6.1. South Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.6.2. South Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.6.7. Biotechnology Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.6.7.2. Rest of Middle East & Africa: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
• 7.7. Biotechnology Market - Latin America
  • 7.7.1. Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
  • 7.7.2. Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.7.3. Biotechnology Market - Mexico
    • 7.7.3.1. Mexico: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.7.3.2. Mexico: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.7.4. Biotechnology Market - Brazil
    • 7.7.4.1. Brazil: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.7.4.2. Brazil: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.7.5. Biotechnology Market - Argentina
    • 7.7.5.1. Argentina: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.7.5.2. Argentina: Biotechnology Market, by Application, 2020-2034 (USD Trillion)
  • 7.7.6. Biotechnology Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Biotechnology Market, by Technology, 2020-2034 (USD Trillion)
    • 7.7.6.2. Rest of Latin America: Biotechnology Market, by Application, 2020-2034 (USD Trillion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Amgen Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. AstraZeneca
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Biogen
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Bristol-Myers Squibb
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. F. Hoffmann-La Roche Ltd.
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Gilead Sciences, Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. Johnson & Johnson Services, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Lonza
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Merck KGaA
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development
• 9.11. Novartis AG
  • 9.11.1. Company Overview
  • 9.11.2. Financial Performance
  • 9.11.3. Product Benchmarking
  • 9.11.4. Recent Development
• 9.12. Novo Nordisk A/S
  • 9.12.1. Company Overview
  • 9.12.2. Financial Performance
  • 9.12.3. Product Benchmarking
  • 9.12.4. Recent Development
• 9.13. Pfizer, Inc
  • 9.13.1. Company Overview
  • 9.13.2. Financial Performance
  • 9.13.3. Product Benchmarking
  • 9.13.4. Recent Development
• 9.14. Sanofi
  • 9.14.1. Company Overview
  • 9.14.2. Financial Performance
  • 9.14.3. Product Benchmarking
  • 9.14.4. Recent Development